α-Linolenic omega-3 fatty acid for stroke protection: From brain preconditioning paradigm to nutrition

OCL - Oleagineux Corps Gras Lipides

Volumn 18, Issue 5, 2011, Pages 271-278

  Blondeau, Nicolas ^a,b  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b CNRS   (France)

Author keywords

Brain preconditioning and tolerance; Nutraceutical; Omega 3 polyunsaturated fatty acids; Prevention; Rapeseed oil; Stroke

Indexed keywords

BRASSICA NAPUS;

EID: 81455154823     PISSN: 12588210     EISSN: 1950697X     Source Type: Journal    
DOI: 10.1684/ocl.2011.0389     Document Type: Article

References (39)

1. Allen CL, Bayraktutan U. Risk factors for ischaemic stroke Int J Stroke 2008; 3: 105-16.
2. Bas O, Songur A, Sahin O, et al. The protective effect of fish n-3 fatty acids on cerebral ischemia in rat hippocampus Neurochem Int 2007; 50: 548-54. (Pubitemid 46186606)
3. Blondeau N, Lauritzen I, Widmann C, Lazdunski M, Heurteaux C. A potent protective role of lysophospholipids against global cerebral ischemia and glutamate excitotoxicity in neuronal cultures. J Cereb Blood Flow Metab 2002a; 22: 821-34. (Pubitemid 34747599)
4. Blondeau N, Nguemeni C, Debruyne DN, et al. Subchronic alpha-linolenic acid treatment enhances brain plasticity and exerts an antidepressant effect: a versatile potential therapy for stroke. Neuropsychopharmacology 2009; 34: 2548-59.
5. Blondeau N, Petrault O, Manta S, et al. Polyunsaturated fatty acids are cerebral vasodilators via the TREK-1 potassium channel. Circ Res 2007; 101: 176-84. (Pubitemid 47196585)
6. Blondeau N, Plamondon H, Richelme C, Heurteaux C, Lazdunski M. K(ATP) channel openers, adenosine agonists and epileptic preconditioning are stress signals inducing hippocampal neuroprotection. Neuroscience 2000; 100: 465-74.
7. Blondeau N, Widmann C, Lazdunski M, Heurteaux C. Activation of the nuclear factor-kappaB is a key event in brain tolerance. J Neurosci 2001; 21: 4668-77. (Pubitemid 32565625)
8. Blondeau N, Widmann C, Lazdunski M, Heurteaux C. Polyunsaturated fatty acids induce ischemic and epileptic tolerance. Neuroscience 2002b; 109: 231-41. (Pubitemid 34098964)
9. Dauchet L, Amouyel P, Dallongeville J. Fruit and vegetable consumption and risk of stroke: a meta-analysis of cohort studies. Neurology 2005; 65: 1193-7. (Pubitemid 41508210)
10. de Goede J, Verschuren WM, Boer JM, Kromhout D, Geleijnse JM. Alpha-linolenic Acid intake and 10-year incidence of coronary heart disease and stroke in 20,000 middle-aged men and women in the Netherlands. PLoS One 2011; 6: e17967.
11. Dirnagl U, Simon RP, Hallenbeck JM. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci 2003; 26: 248-54. (Pubitemid 36556155)
12. Endres M, Dirnagl U. Ischemia and stroke. Adv Exp Med Biol 2002; 513: 455-73. (Pubitemid 36332418)
13. Fink M, Lesage F, Duprat F, et al. A neuronal two P domain K+ channel stimulated by arachidonic acid and polyunsaturated fatty acids. EMBO J 1998; 17: 3297-308. (Pubitemid 28279504)
14. Gidday JM. Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci 2006; 7: 437-48. (Pubitemid 44012284)
15. Heurteaux C, Laigle C, Blondeau N, Jarretou G, Lazdunski M. Alpha-linolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia. Neuroscience 2006; 137: 241-51. (Pubitemid 43031491)
16. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 2004; 5: 347-60. (Pubitemid 38568496)
17. Jonas S, Ayigari V, Viera D, Waterman P. Neuroprotection against cerebral ischemia. A review of animal studies and correlation with human trial results. Ann N Y Acad Sci 1999; 890: 2-3. (Pubitemid 30040359)
18. Kirino T. Ischemic tolerance. J Cereb Blood Flow Metab 2002; 22: 1283-96. (Pubitemid 35285085)
19. Kitagawa K, Matsumoto M, Tagaya M, et al. 'Ischemic tolerance' phenomenon found in the brain. Brain Res 1990; 528: 21-4. (Pubitemid 20292932)
20. Lauritzen I, Blondeau N, Heurteaux C, Widmann C, Romey G, Lazdunski M. Polyunsaturated fatty acids are potent neuroprotectors. EMBO J 2000; 19: 1784-93. (Pubitemid 30204390)
21. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010; 121: e46-e215.
22. Lo EH. Experimental models, neurovascular mechanisms and translational issues in stroke research. Br J Pharmacol 2008; 153 (Suppl. 1): S396-405. (Pubitemid 351341004)
23. Lo EH, Rosenberg GA. The neurovascular unit in health and disease: introduction. Stroke 2009; 40: S2-3.
24. Minnerup J, Schabitz WR. Multifunctional actions of approved and candidate stroke drugs. Neurotherapeutics 2009; 6: 43-52.
25. Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron 2010; 67: 181-98.
26. Nguemeni C, Delplanque B, Rovere C, et al. Dietary supplementation of alpha-linolenic acid in an enriched rapeseed oil diet protects from stroke. Pharmacol Res 2010, 61; 226-33.
27. O'Duffy AE, Bordelon YM, McLaughlin B. Killer proteases and little strokes-how the things that do not kill you make you stronger. J Cereb Blood Flow Metab 2007; 27: 655-68. (Pubitemid 46474612)
28. Obrenovitch TP. Molecular physiology of preconditioning-induced brain tolerance to ischemia. Physiol Rev 2008; 88: 211-47.
29. Ozen OA, Cosar M, Sahin O, et al. The protective effect of fish n-3 fatty acids on cerebral ischemia in rat prefrontal cortex. Neurol Sci 2008; 29: 147-52. (Pubitemid 352003649)
30. Plamondon H, Blondeau N, Heurteaux C, Lazdunski M. Mutually protective actions of kainic acid epileptic preconditioning and sublethal global ischemia on hippocampal neuronal death: involvement of adenosine A1 receptors and K(ATP) channels. J Cereb Blood Flow Metab 1999; 19: 1296-308. (Pubitemid 30013620)
31. Pulsinelli WA, Brierley JB. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 1979; 10: 267-72. (Pubitemid 9141527)
32. Relton JK, Strijbos PJ, Cooper AL, Rothwell NJ. Dietary N-3 fatty acids inhibit ischaemic and excitotoxic brain damage in the rat. Brain Res Bull 1993; 32: 223-6. (Pubitemid 23210273)
33. Riediger ND, Othman RA, Suh M, Moghadasian MH. A systemic review of the roles of n-3 fatty acids in health and disease. J Am Diet Assoc 2009; 109: 668-79.
34. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117: e25- 146.
35. Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 2008; 233: 674-88.
36. Tauskela JS, Blondeau N. 2009 In: Ischemic Tolerance of the Brain, Research Signpost. Schaller, BJ, Ed.; Kerala, India : Research Signpost, 2009: 85-135.
37. Weih M, Kallenberg K, Bergk A, et al. Attenuated stroke severity after prodromal TIA: a role for ischemic tolerance in the brain? Stroke 1999; 30: 1851-4. (Pubitemid 29411826)
38. Zaleska MM, Mercado ML, Chavez J, Feuerstein GZ, Pangalos MN, Wood A. The development of stroke therapeutics: promising mechanisms and translational challenges. Neuropharmacology 2009; 56: 329-41.
39. Zhang ZG, Chopp M. Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol 2009; 8: 491-500.